Literature DB >> 21626001

[Motor neuron diseases].

S Petri1, T Meyer.   

Abstract

Motor neuron diseases (MND) are a group of neurodegenerative disorders which are present in clinical, prognostic and genetic diversity. The most common MND are amyotrophic lateral sclerosis (ALS), proximal spinal muscular atrophy (SMA) and various forms of hereditary and sporadic lower motor neuron syndromes including hereditary motor neuropathies (HMN). Familial and "sporadic" forms of ALS and lower motor neuron syndromes are known. The essential pathogenic findings in MND have emerged from molecular biological examinations of the hereditary forms of MND. In ALS, one consistent neuropathological feature is intraneuronal protein inclusions which arise from TDP-43, FUS, SOD1 or ataxin-2 aggregations. TDP-43, FUS, SOD1 and ataxin-2 are multifunctional DNA/RNA-binding proteins which are involved in transcription regulation. SMA and HMN are associated with different genes whose gene products may also be involved in RNA processing. A disturbance in the regulation of RNA possibly represents an overlapping pathophysiological characteristic in MND. The elucidation of common pathways in the cascade of motor neuron degeneration is an essential point of departure for molecular genetically defined treatment strategies both in ALS and in hereditary and sporadic lower motor neuron syndromes.

Entities:  

Mesh:

Year:  2011        PMID: 21626001     DOI: 10.1007/s00115-010-2967-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  52 in total

1.  Neurodegeneration: An expansion in ALS genetics.

Authors:  Clotilde Lagier-Tourenne; Don W Cleveland
Journal:  Nature       Date:  2010-08-26       Impact factor: 49.962

2.  Frontotemporal cognitive function in X-linked spinal and bulbar muscular atrophy (SBMA): a controlled neuropsychological study of 20 patients.

Authors:  Georg Rüdiger Soukup; Anne-Dorte Sperfeld; Ingo Uttner; Jochen Karitzky; Albert Christian Ludolph; Jan Kassubek; Herbert Schreiber
Journal:  J Neurol       Date:  2009-07-02       Impact factor: 4.849

Review 3.  Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA).

Authors:  Masahisa Katsuno; Haruhiko Banno; Keisuke Suzuki; Hiroaki Adachi; Fumiaki Tanaka; Gen Sobue
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 4.  An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).

Authors:  B Wirth
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

5.  Clinical spectrum and diagnostic criteria of infantile spinal muscular atrophy: further delineation on the basis of SMN gene deletion findings.

Authors:  S Rudnik-Schöneborn; R Forkert; E Hahnen; B Wirth; K Zerres
Journal:  Neuropediatrics       Date:  1996-02       Impact factor: 1.947

Review 6.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

7.  Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Authors:  Ian R A Mackenzie; Eileen H Bigio; Paul G Ince; Felix Geser; Manuela Neumann; Nigel J Cairns; Linda K Kwong; Mark S Forman; John Ravits; Heather Stewart; Andrew Eisen; Leo McClusky; Hans A Kretzschmar; Camelia M Monoranu; J Robin Highley; Janine Kirby; Teepu Siddique; Pamela J Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

8.  A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes.

Authors:  Renske M Van den Berg-Vos; Jeldican Visser; Sandra Kalmijn; Kathelijn Fischer; Marianne de Visser; Vianney de Jong; Rob J de Haan; Hessel Franssen; John H J Wokke; Leonard H Van den Berg
Journal:  Arch Neurol       Date:  2009-06

9.  Monomelic neurogenic syndromes: a prospective study.

Authors:  Mamede de Carvalho; Michael Swash
Journal:  J Neurol Sci       Date:  2007-07-03       Impact factor: 3.181

10.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.